NovaBridge Biosciences (NBP) Shares Outstanding (2020 - 2026)

NovaBridge Biosciences (NBP) has reported Shares Outstanding (Entity) for 8 consecutive years, with $95.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) rose 17.96% year-over-year to $95.8 million; the TTM figure through Dec 2025 stood at $95.8 million (up 17.96% YoY), while the FY2025 annual figure was $95.8 million, up 17.96% from the prior year.
• Shares Outstanding (Entity) improved to $95.8 million in Q4 2025 per NBP's latest filing, from $89.2 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $95.8 million in Q4 2025 and bottomed at $47.9 million in Q2 2021.
• Historically, Shares Outstanding (Entity) has averaged $72.0 million across 5 years, with a median of $81.1 million in 2024.
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) decreased 9.6% — and 2023, when it soared 54.64%.
• NovaBridge Biosciences' Shares Outstanding (Entity) stood at $49.5 million in 2021, then climbed by 8.63% to $53.8 million in 2022, then jumped by 54.64% to $83.2 million in 2023, then dropped by 2.45% to $81.2 million in 2024, then rose by 17.96% to $95.8 million in 2025.
• Business Quant data shows NBP's Shares Outstanding (Entity) at $95.8 million in Q4 2025, $89.2 million in Q3 2025, and $81.6 million in Q2 2025.